Back to List View Graph View

Cardiovascular disease

Cardiovascular disease (CVD) is an umbrella term encompassing a broad spectrum of disorders affecting the heart and blood vessels, including coronary artery disease (CAD), heart failure, stroke, peripheral artery disease, and arrhythmias such as atrial fibrillation/flutter.

Where the papers sit

18 papers from the last 6 months study cardiovascular disease directly · updated from PubMed 10 Oct 2026

  • Multimodal Cardiovascular Risk Prediction

    Cardiovascular risk assessment is moving toward integrated models that combine phenotypic aging, genetics, lifestyle, metabolic inflammation, and routine clinical data. Cox models, random survival forests, ensemble machine learning, and imputation refine prediction across CKM stages. Lp(a)-carried triglycerides and ASGR1 emerge as candidate biomarkers, while sclerostin inhibition is examined for atrial fibrillation risk. External validation and clinically actionable biomarkers remain open.

    8 papers · 44.4%

  • Cardiometabolic Disease Prevention

    Cardiometabolic care is shifting toward earlier detection and behavior change across diabetes, metabolic syndrome, and vascular damage. Fitbit tracking and tailored text messages test whether reducing sedentary time is feasible and effective. Free-text clinical records and interpretable deep learning broaden heart-disease prediction beyond conventional tabular data. Inflammation, aging, and post-transplant risk remain important sources of heterogeneity.

    5 papers · 27.8%

  • Type 2 Diabetes Comorbidity

    Type 2 diabetes is being framed as a multisystem condition with linked cardio-renal, mental-health, and substance-use burdens. Cohort analyses track sex-specific trajectories after diabetes onset, while hospitalization studies focus on diabetic-foot-ulcer readmission. Cannabis, opioid, and cocaine use disorders identify subgroups with higher cardiovascular mortality risk. The recurring gap is whether integrated mental-health and cardiometabolic care can reduce these outcomes.

    3 papers · 16.7%

  • Environmental Cardiovascular Risk

    Environmental cardiovascular epidemiology is focusing on exposures that may modify risk across aging populations. Mixed-metal analyses highlight cadmium alongside other contaminants, while nationwide humidity metrics test climate-related associations. The evidence is primarily population-based and observational, emphasizing exposure measurement and cardiovascular outcomes rather than treatment. Causal pathways and clinically useful thresholds remain unresolved.

    2 papers · 11.1%

Papers

The 18 papers from the last 6 months that study cardiovascular disease directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.

By theme

Multimodal Cardiovascular Risk Prediction (8)
  1. Frailty index deficit interchangeability: an empirical test using random survival forests in adults with cardiovascular disease. Age and ageing · 4 Sept 2026 PMID 42696642
  2. Lipoprotein(a) carries triglyceride species associated with incident cardiovascular disease. Atherosclerosis · 18 Aug 2026 PMID 42612337
  3. Dynamic Co-Evolution of Obesity-Metabolic-Inflammatory for Cardiovascular Disease Risk Stratification in Middle-Aged and Older Adults: A Data-Driven Joint Trajectory Analysis. Clinical cardiology · 29 Jul 2026 PMID 42522468
  4. Proxied therapeutic inhibition on sclerostin and atrial fibrillation risk. Communications medicine · 30 May 2026 PMID 42218280
  5. Associations of accelerated phenotypic aging, genetic risk and lifestyle with incident asthma, subsequent cardiovascular disease and death: A prospective study using multi-state model. Maturitas · 25 May 2026 PMID 42184546
  6. SPISE index and ensemble machine learning refine cardiovascular risk stratification in stage 0-3 CKM syndrome. The aging male : the official journal of the International Society for the Study of the Aging Male · 8 May 2026 PMID 42101474
  7. Elevated ASGR1 as a Potential Diagnostic Biomarker for Coronary Artery Disease and Predictor of Adverse Outcomes in Hypertensive Patients. FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 28 Apr 2026 PMID 42048115
  8. Urinary Proteomics: Biological Foundations, Analytical Frameworks, and Clinical Translation Across Human Diseases. Genomics, proteomics & bioinformatics · 23 Apr 2026 PMID 42024578
Cardiometabolic Disease Prevention (5)
  1. Feasibility and Preliminary Efficacy of a "Sit Less" Program Leveraging Fitbit Tracking and Tailored Text Messages in Cardiometabolic Disease: Findings From 2 Parallel Randomized Controlled Trials in Coronary Artery Disease and Type 2 Diabetes. JMIR mHealth and uHealth · 25 Aug 2026 PMID 42641078
  2. Leveraging free-text clinical records for heart disease classification through structured feature mapping. PloS one · 27 Jul 2026 PMID 42507733
  3. Prevalence of and Risk Factors for Metabolic Syndrome, Vascular Damage, and Accelerated Aging (MetVasA) After Pediatric Hematopoietic Stem Cell Transplantation for Hematological Malignancy: Protocol for a Cross-Sectional Cohort Study. JMIR research protocols · 16 Jun 2026 PMID 42302269
  4. A modular deep learning architecture for interpretable disease prediction across tabular clinical and biometric datasets. PloS one · 8 May 2026 PMID 42102106
  5. Association between chronic low-grade inflammation and metabolic syndrome and their impact on the risk of coronary artery disease in type 1 diabetes. Journal of diabetes and its complications · 29 Apr 2026 PMID 42054898
Type 2 Diabetes Comorbidity (3)
  1. Sex differences in trajectories to cardio-renal and mental health outcomes following the onset of type 2 diabetes: An observational cohort study using multi-state analysis in the UK Clinical Practice Research Datalink. PLoS medicine · 25 Aug 2026 PMID 42640878
  2. Elevated Cardiovascular Risk and Mortality in Type 2 Diabetes Mellitus Patients With Cannabis, Opioid, and Cocaine Use Disorders. Diabetes, obesity & metabolism · 15 Jun 2026 PMID 42297744
  3. Thirty-Day Readmission After Hospitalisation for Diabetic Foot Ulcer: A Nationwide Analysis. Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society · 29 Apr 2026 PMID 42053128
Environmental Cardiovascular Risk (2)
  1. Association of Mixed Metal Exposures with Cardiovascular Disease: Insights from a Population-Based Study. Cardiovascular toxicology · 3 Oct 2026 PMID 42828596
  2. Absolute and physiological humidity metrics and cardiovascular disease risk in aging: a nationwide study from China. International journal of biometeorology · 27 May 2026 PMID 42201577

By study type

Clinical trials (1)
  1. Feasibility and Preliminary Efficacy of a "Sit Less" Program Leveraging Fitbit Tracking and Tailored Text Messages in Cardiometabolic Disease: Findings From 2 Parallel Randomized Controlled Trials in Coronary Artery Disease and Type 2 Diabetes. JMIR mHealth and uHealth · 25 Aug 2026 PMID 42641078
Observational studies and case reports (9)
  1. Association of Mixed Metal Exposures with Cardiovascular Disease: Insights from a Population-Based Study. Cardiovascular toxicology · 3 Oct 2026 PMID 42828596
  2. Sex differences in trajectories to cardio-renal and mental health outcomes following the onset of type 2 diabetes: An observational cohort study using multi-state analysis in the UK Clinical Practice Research Datalink. PLoS medicine · 25 Aug 2026 PMID 42640878
  3. Lipoprotein(a) carries triglyceride species associated with incident cardiovascular disease. Atherosclerosis · 18 Aug 2026 PMID 42612337
  4. Dynamic Co-Evolution of Obesity-Metabolic-Inflammatory for Cardiovascular Disease Risk Stratification in Middle-Aged and Older Adults: A Data-Driven Joint Trajectory Analysis. Clinical cardiology · 29 Jul 2026 PMID 42522468
  5. Prevalence of and Risk Factors for Metabolic Syndrome, Vascular Damage, and Accelerated Aging (MetVasA) After Pediatric Hematopoietic Stem Cell Transplantation for Hematological Malignancy: Protocol for a Cross-Sectional Cohort Study. JMIR research protocols · 16 Jun 2026 PMID 42302269
  6. Absolute and physiological humidity metrics and cardiovascular disease risk in aging: a nationwide study from China. International journal of biometeorology · 27 May 2026 PMID 42201577
  7. Associations of accelerated phenotypic aging, genetic risk and lifestyle with incident asthma, subsequent cardiovascular disease and death: A prospective study using multi-state model. Maturitas · 25 May 2026 PMID 42184546
  8. SPISE index and ensemble machine learning refine cardiovascular risk stratification in stage 0-3 CKM syndrome. The aging male : the official journal of the International Society for the Study of the Aging Male · 8 May 2026 PMID 42101474
  9. Thirty-Day Readmission After Hospitalisation for Diabetic Foot Ulcer: A Nationwide Analysis. Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society · 29 Apr 2026 PMID 42053128
Human data, design not indexed (5)
  1. Frailty index deficit interchangeability: an empirical test using random survival forests in adults with cardiovascular disease. Age and ageing · 4 Sept 2026 PMID 42696642
  2. Leveraging free-text clinical records for heart disease classification through structured feature mapping. PloS one · 27 Jul 2026 PMID 42507733
  3. A modular deep learning architecture for interpretable disease prediction across tabular clinical and biometric datasets. PloS one · 8 May 2026 PMID 42102106
  4. Association between chronic low-grade inflammation and metabolic syndrome and their impact on the risk of coronary artery disease in type 1 diabetes. Journal of diabetes and its complications · 29 Apr 2026 PMID 42054898
  5. Elevated ASGR1 as a Potential Diagnostic Biomarker for Coronary Artery Disease and Predictor of Adverse Outcomes in Hypertensive Patients. FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 28 Apr 2026 PMID 42048115
Unclassified: not yet indexed with MeSH (3)
  1. Elevated Cardiovascular Risk and Mortality in Type 2 Diabetes Mellitus Patients With Cannabis, Opioid, and Cocaine Use Disorders. Diabetes, obesity & metabolism · 15 Jun 2026 PMID 42297744
  2. Proxied therapeutic inhibition on sclerostin and atrial fibrillation risk. Communications medicine · 30 May 2026 PMID 42218280
  3. Urinary Proteomics: Biological Foundations, Analytical Frameworks, and Clinical Translation Across Human Diseases. Genomics, proteomics & bioinformatics · 23 Apr 2026 PMID 42024578